Genotypic resistance analyses in nucleoside-pretreated patients failing an indinavir containing regimen: results from a randomized comparative trial: (Novavir ANRS 073)
- 30 June 2005
- journal article
- clinical trial
- Published by Elsevier in Journal of Clinical Virology
- Vol. 33 (2), 99-103
- https://doi.org/10.1016/j.jcv.2004.05.019
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2003 Recommendations of an International AIDS Society–USA PanelClinical Infectious Diseases, 2003
- Efficacy of Zidovudine Compared to Stavudine, Both in Combination with Lamivudine and Indinavir, in Human Immunodeficiency Virus-Infected Nucleoside-Experienced Patients with No Prior Exposure to Lamivudine, Stavudine, or Protease Inhibitors (Novavir Trial)Antimicrobial Agents and Chemotherapy, 2002
- Emergence of Resistance to Protease Inhibitor Amprenavir in Human Immunodeficiency Virus Type 1-Infected Patients: Selection of Four Alternative Viral Protease Genotypes and Influence of Viral Susceptibility to Coadministered Reverse Transcriptase Nucleoside InhibitorsAntimicrobial Agents and Chemotherapy, 2002
- Drug resistance in patients experiencing early virological failure under a triple combination including indinavirAIDS, 2001
- HIV-1 subtyping using phylogenetic analysis of pol gene sequencesJournal of Virological Methods, 2001
- Absence of zidovudine resistance in antiretroviral-naive patients following zidovudine/lamivudine/protease inhibitor combination therapy: virological evaluation of the AVANTI 2 and AVANTI 3 studiesAIDS, 2000
- Mechanisms of Virologic Failure in Previously Untreated HIV-Infected Patients From a Trial of Induction-Maintenance TherapyJAMA, 2000
- Ordered accumulation of mutations in HIV protease confers resistance to ritonavirNature Medicine, 1996
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsNature, 1995
- Determination of L-735 524, an human immunodeficiency virus protease inhibitor, in human plasma and urine via high-performance liquid chromatography with column switchingJournal of Chromatography A, 1995